ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Helix Biomedix Inc (PK)

Helix Biomedix Inc (PK) (HXBM)

12.00
-3.35
(-21.82%)
Closed December 18 4:00PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
12.00
Bid
3.11
Ask
17.99
Volume
108
12.00 Day's Range 12.00
12.00 52 Week Range 23.50
Market Cap
Previous Close
15.35
Open
12.00
Last Trade
8
@
10.59
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
183
Shares Outstanding
224,708
Dividend Yield
-
PE Ratio
-3.27
Earnings Per Share (EPS)
-4.7
Revenue
998k
Net Profit
-1.06M

About Helix Biomedix Inc (PK)

Helix BioMedix is a preclinical biopharmaceutical company focused on drug development for treatment of rare dermatological diseases, such as xeroderma pigmentosum. Our legacy R&D consists of an extensive proprietary library of patented bioactive peptides based on the body's innate immunity many of w... Helix BioMedix is a preclinical biopharmaceutical company focused on drug development for treatment of rare dermatological diseases, such as xeroderma pigmentosum. Our legacy R&D consists of an extensive proprietary library of patented bioactive peptides based on the body's innate immunity many of which the company has outlicensed to partners to commercialize. Helix BioMedix, Inc., is committed to building long term shareholder value through development of novel drugs for rare dermatological conditions with unmet needs and strategic management of our diverse peptide library. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Bothell, USA
Founded
-
Helix Biomedix Inc (PK) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker HXBM. The last closing price for Helix Biomedix (PK) was $15.35. Over the last year, Helix Biomedix (PK) shares have traded in a share price range of $ 12.00 to $ 23.50.

Helix Biomedix (PK) currently has 224,708 shares outstanding. The market capitalization of Helix Biomedix (PK) is $3.45 million. Helix Biomedix (PK) has a price to earnings ratio (PE ratio) of -3.27.

HXBM Latest News

Tier Change

Fri, Jun 28, 2013 12:00 - Helix BioMedix, Inc. (HXBM: OTC Pink Limited) - Tier Change - The symbol, HXBM, no longer is classified as OTC Pink Limited. As of Fri, Jun 28, 2013, HXBM resides in the...

Helix BioMedix, Inc. (HXBMD: OTC Link) | Symbol Change

Fri, Feb 01, 2013 12:00 - Helix BioMedix, Inc. (HXBMD: OTC Link) - Symbol Change - The symbol, HXBMD, is no longer a valid symbol for Helix BioMedix, Inc.. As of Fri, Feb 01, 2013, the new...

Deleted Symbol

Thu, Jan 03, 2013 12:00 - Helix BioMedix, Inc. (HXBM: OTC Link) - Deleted Symbol - As of Thu, Jan 03, 2013, HXBM is no longer a valid symbol. You may find a complete list of deleted symbols at...

Ex-Dividend

Wed, Jan 02, 2013 08:00 - Helix BioMedix, Inc. (HXBM: OTC Link) - Ex-Dividend - As of Thu, Jan 03, 2013, Helix BioMedix, Inc. traded ex-dividend. Helix BioMedix, Inc. will disburse a Reverse...

Scheduled Ex-Dividend

Wed, Jan 02, 2013 08:00 - Helix BioMedix, Inc. (HXBM: OTC Link) - Scheduled Ex-Dividend - Helix BioMedix, Inc. has announced a dividend ex-date for (HXBM: OTC Link). Helix BioMedix, Inc. is...

Helix BioMedix Reports Third Quarter 2012 Financial Results

Helix BioMedix, Inc. (OTCQB: HXBM), a developer of bioactive peptides, today announced financial results for the third quarter ended September 30, 2012. Third Quarter 2012...

Helix BioMedix Announces Plan for Voluntary Suspension of SEC Reporting Obligations

Helix BioMedix, Inc. (OTCQB: HXBM) (the “Company”), a developer of bioactive peptides, today announced that it has filed a Schedule 13E-3 and related preliminary proxy statement...

Helix BioMedix Reports Second Quarter 2012 Financial Results; Launches New Apothederm™ Acne Clarifying Treatment

Helix BioMedix, Inc. (OTCQB: HXBM), a developer of bioactive peptides, today announced financial results for the second quarter ended June 30, 2012. Second Quarter 2012...

Helix BioMedix Reports First Quarter 2012 Financial Results

Helix BioMedix, Inc. (OTCQB: HXBM), a developer of bioactive peptides, today announced financial results for the first quarter ended March 31, 2012. First Quarter 2012...

Helix BioMedix Reports Record 2011 Financial Results

Helix BioMedix, Inc. (OTCQB: HXBM), a developer of bioactive peptides, today announced financial results for the year ended December 31, 2011. 2011 Financial and Business...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
100012000CS
400012000CS
12-6-33.333333333318181218315.45454545CS
26-11.5-48.936170212823.523.51215317.51383178CS
52-11.27-48.431456811323.2723.51213319.40121859CS
156-9.99999999998E-5-0.00083332638894512.0001261219920.6102671CS
260-29.2-70.873786407841.241.21222224.00222176CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
IBKKFImining Technologies Inc (CE)
$ 0.05
(4,999,900.00%)
833
WRCDFWirecard AG (CE)
$ 0.01
(999,900.00%)
250
SLAAFSitios Latinoamerica SAB de CV (PK)
$ 0.189
(94,400.00%)
21.85k
MIKPMike The Pike Productions Inc (CE)
$ 0.0002
(19,900.00%)
520k
KBNTKubient Inc (CE)
$ 0.0002
(19,900.00%)
1.48k
AMHGQAmergent Hospitality Group Inc (CE)
$ 0.000001
(-100.00%)
76.67k
CLVRClever Leaves Holdings Inc (CE)
$ 0.000001
(-100.00%)
240
NEPTFNeptune Wellness Solutions Inc (CE)
$ 0.000001
(-100.00%)
3.72k
ORMTQOrmet Corp (CE)
$ 0.000001
(-99.99%)
500k
RKIGFReko International Group Inc (PK)
$ 0.0006
(-99.98%)
100
RDARRaadr Inc (PK)
$ 0.001
(-28.57%)
320.76M
HMBLHUMBL Inc (PK)
$ 0.0012
(-4.00%)
311.02M
MMEXMMEX Resources Corporation (PK)
$ 0.0001
(9,900.00%)
265.88M
EARIEntertainment Arts Research Inc (PK)
$ 0.0001
(0.00%)
213.32M
CGACCode Green Apparel Corp (PK)
$ 0.0005
(-16.67%)
125.52M